South & Central America Infusion Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The South and Central America infusion devices market is projected to grow significantly, reaching an estimated US$ 1,164.42 million by 2031, up from US$ 722.52 million in 2023, reflecting a compound annual growth rate (CAGR) of 6.1% during this period.

Executive Summary and Market Analysis

This market is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. Brazil, in particular, has seen technological advancements that positively impact its economy, making it an attractive location for manufacturing due to benefits like cost-effectiveness and improved operational efficiencies. The infusion devices market in this region is characterized by numerous prominent players who are actively working to increase their market presence through strategic initiatives, including product innovation, partnerships, and regional expansion. Key companies in this sector include Abbott, B. Braun Melsungen AG, Baxter International Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medline Industries, Inc., and Medtronic. These firms are enhancing their product offerings and distribution networks to meet the rising demand for infusion devices. Notably, the insulin infusion pump segment is expected to grow at a CAGR of 6.3% from 2025 to 2030, driven by technological advancements, regulatory changes, and the increasing prevalence of chronic diseases, which boost the need for advanced infusion therapies.

Market Segmentation Analysis

The South and Central America infusion devices market can be segmented by product type, application, and end user.

Product Type: The market is divided into infusion pumps and infusion sets, with infusion pumps holding a larger market share in 2023. Within infusion pumps, volumetric pumps, syringe pumps, insulin pumps, patient-controlled analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps are included, with volumetric pumps leading the market.
Infusion Sets: This segment is categorized into vented and non-vented infusion sets, where vented sets dominated in 2023.
Application: The market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others, with diabetes being the largest segment in 2023.
End User: The end-user categories include hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others, with hospitals and specialty clinics holding the largest share.

Market Outlook

Market players are focusing on strategic developments such as product launches, mergers, acquisitions, and collaborations to create advanced products that facilitate the treatment of chronic conditions like diabetes, cancer, and chronic pain. Recent developments include:

In February 2023, Mindray introduced its BeneFusion i Series and u Series infusion systems, designed for high precision and medication safety across various clinical settings.
In March 2022, Fresenius Kabi received FDA clearance for its Agilia Connect Infusion System, which includes advanced volumetric and syringe pumps.
In January 2021, Eitan Medical launched operations in the UK to enhance support for its Sapphire infusion pump customers.

These advancements indicate a growing trend of product approvals and strategic collaborations, which are expected to create lucrative opportunities in the infusion devices market.

Country Insights

The market is primarily composed of Brazil, Argentina, and the Rest of South and Central America, with Brazil holding the largest market share in 2023. Brazil is among the top ten countries with the highest diabetes prevalence, affecting approximately 16.8 million individuals. This rising incidence of diabetes has led to a significant increase in cardiovascular disease risk, thereby driving the demand for infusion pumps. Local companies like Lifemed S.A. are also focusing on product development to enhance their market share alongside international competitors.

Company Profiles

Key players in the South and Central America infusion devices market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Fresenius Kabi AG, ICU Medical Inc, Medtronic Plc, and others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to deliver innovative solutions and increase their market presence.

Product Code: BMIRE00032022

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Infusion Devices Market Landscape

4.1 PEST Analysis

5. South & Central America Infusion Devices Market - Key Market Dynamics

5.1 South & Central America Infusion Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Cancer
- 5.2.2 Growing Geriatric Population
5.3 Market Restraints
- 5.3.1 Frequent Product Recalls of Infusion Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Growing Technological Advancements
5.6 Impact of Drivers and Restraints:

6. South & Central America Infusion Devices Market - Analysis

6.1 South & Central America Infusion Devices Market Revenue (US$ Million), 2021-2031
6.2 South & Central America Infusion Devices Market Forecast Analysis

7. South & Central America Infusion Devices Market Analysis - by Product Type

7.1 Infusion Pumps
- 7.1.1 Overview
- 7.1.2 Infusion Pumps: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Infusion Sets
- 7.2.1 Overview
- 7.2.2 Infusion Sets: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Infusion Devices Market Analysis - by Application

8.1 Diabetes
- 8.1.1 Overview
- 8.1.2 Diabetes: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Oncology: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Hematology
- 8.4.1 Overview
- 8.4.2 Hematology: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Pediatrics
- 8.5.1 Overview
- 8.5.2 Pediatrics: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Gastroenterology
- 8.6.1 Overview
- 8.6.2 Gastroenterology: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Infusion Devices Market Analysis - by End User

9.1 Hospitals and Specialty Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Specialty Clinics: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Homecare Settings
- 9.2.1 Overview
- 9.2.2 Homecare Settings: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Infusion Devices Market - Country Analysis

10.1 South & Central America
- 10.1.1 South & Central America Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 South & Central America Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Brazil: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Brazil: South & Central America Infusion Devices Market Share - by Product Type
    - 10.1.1.2.2 Brazil: South & Central America Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.2.3 Brazil: South & Central America Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.2.4 Brazil: South & Central America Infusion Devices Market Share - by Application
    - 10.1.1.2.5 Brazil: South & Central America Infusion Devices Market Share - by End User
  - 10.1.1.3 Argentina: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Argentina: South & Central America Infusion Devices Market Share - by Product Type
    - 10.1.1.3.2 Argentina: South & Central America Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.3.3 Argentina: South & Central America Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.3.4 Argentina: South & Central America Infusion Devices Market Share - by Application
    - 10.1.1.3.5 Argentina: South & Central America Infusion Devices Market Share - by End User
  - 10.1.1.4 Rest of South & Central America: South & Central America Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Rest of South & Central America: South & Central America Infusion Devices Market Share - by Product Type
    - 10.1.1.4.2 Rest of South & Central America: South & Central America Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.4.3 Rest of South & Central America: South & Central America Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.4.4 Rest of South & Central America: South & Central America Infusion Devices Market Share - by Application
    - 10.1.1.4.5 Rest of South & Central America: South & Central America Infusion Devices Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Infusion Devices Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Fresenius Kabi AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 B Braun SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 CODAN US Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Elimedical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ICU Medical Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 BPL Medical Technologies Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Nipro Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 KD Scientific Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Medtronic Plc
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Zimed Healthcare Ltd
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Terumo Corp
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Eitan Medical Ltd
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Polymedicure
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Financial Overview
- 12.15.4 SWOT Analysis
- 12.15.5 Key Developments
12.16 Moog Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Tandem Diabetes Care Inc
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments

13. Appendix

13.1 About The Insight Partners